Deferred Tax Assets, Valuation Allowance of AbbVie Inc. from 31 Dec 2012 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
- Summary
-
AbbVie Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
- AbbVie Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $15,018,000,000, a 1.3% increase year-over-year.
- Source SEC data
- View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)
AbbVie Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $15,018,000,000 | +$195,000,000 | +1.3% | 31 Dec 2025 | 10-K | 20 Feb 2026 | 2025 | FY |
| Q4 2024 | $14,823,000,000 | +$1,345,000,000 | +10% | 31 Dec 2024 | 10-K | 20 Feb 2026 | 2025 | FY |
| Q4 2023 | $13,478,000,000 | +$3,851,000,000 | +40% | 31 Dec 2023 | 10-K | 14 Feb 2025 | 2024 | FY |
| Q4 2022 | $9,627,000,000 | +$236,000,000 | +2.5% | 31 Dec 2022 | 10-K | 20 Feb 2024 | 2023 | FY |
| Q4 2021 | $9,391,000,000 | +$8,188,000,000 | +681% | 31 Dec 2021 | 10-K | 17 Feb 2023 | 2022 | FY |
| Q4 2020 | $1,203,000,000 | +$472,000,000 | +65% | 31 Dec 2020 | 10-K | 18 Feb 2022 | 2021 | FY |
| Q4 2019 | $731,000,000 | +$628,000,000 | +610% | 31 Dec 2019 | 10-K | 19 Feb 2021 | 2020 | FY |
| Q4 2018 | $103,000,000 | -$5,000,000 | -4.6% | 31 Dec 2018 | 10-K | 21 Feb 2020 | 2019 | FY |
| Q4 2017 | $108,000,000 | +$32,000,000 | +42% | 31 Dec 2017 | 10-K | 27 Feb 2019 | 2018 | FY |
| Q4 2016 | $76,000,000 | +$6,000,000 | +8.6% | 31 Dec 2016 | 10-K | 16 Feb 2018 | 2017 | FY |
| Q4 2015 | $70,000,000 | -$102,000,000 | -59% | 31 Dec 2015 | 10-K | 17 Feb 2017 | 2016 | FY |
| Q4 2014 | $172,000,000 | +$129,000,000 | +300% | 31 Dec 2014 | 10-K | 19 Feb 2016 | 2015 | FY |
| Q4 2013 | $43,000,000 | +$36,000,000 | +514% | 31 Dec 2013 | 10-K | 20 Feb 2015 | 2014 | FY |
| Q4 2012 | $7,000,000 | 31 Dec 2012 | 10-K | 21 Feb 2014 | 2013 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.